Gelesis

(OTC) GLSHQ

Current Price$0.00

Market Cap$100

Since IPO (2020)-100%

5 Year-100%

1 Year-99%

1 Month+0%

Gelesis Financials at a Glance

Market Cap

$100

Revenue (TTM)

$12.14M

Net Income (TTM)

$51.67M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-299.29 (Low)

Dividend

$0.00

Beta (Volatility)

-299.29 (Low)

Price

$0.00

Volume

500

Open

$0.00

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

-299.29 (Low)

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

GLSHQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gelesis

Industry

Biotechnology

Sector

Health Care

Employees

100

CEO

Yishai Zohar

Website

www.gelesis.com

Headquarters

Boston, MA 02116, US

GLSHQ Financials

Key Financial Metrics (TTM)

Gross Margin

-7%

Operating Margin

-5%

Net Income Margin

-2%

Return on Equity

Return on Capital

-2%

Return on Assets

-54%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

73.34M

Volume

500

Avg. Volume

9.587

Financials (TTM)

Gross Profit

$1.79M

Operating Income

$121.81M

EBITDA

$48.35M

Operating Cash Flow

$77.73M

Capital Expenditure

$9.12M

Free Cash Flow

$86.85M

Cash & ST Invst.

$7.41M

Total Debt

$62.26M

Gelesis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2023YOY CHG

Revenue

$1.11M

-87.7%

Gross Profit

$609.00K

-85.5%

Gross Margin

55.01%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$1.08

N/A

Employees

N/A

Net Income

$7.68M

+39.0%

EBITDA

$4.88M

+56.5%

Quarterly Fundamentals

Name

Q2 2023YOY CHG

Net Cash

$53.97M

-460.8%

Accounts Receivable

$9.56M

-32.2%

Inventory

$5.69M

-69.8%

Long Term Debt

$27.96M

-10.5%

Short Term Debt

$33.91M

+809.9%

Return on Assets

-53.99%

N/A

Return on Invested Capital

-2.31%

N/A

Free Cash Flow

$599.00K

+107.8%

Operating Cash Flow

$617.00K

+113.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GNBTGenerex Biotechnology Corporation

GNBTGenerex Biotechnology Corporation$0.00+0.00%

GTHRGeneThera, Inc.

GTHRGeneThera, Inc.$0.00+0.00%

CRYOAmerican CryoStem Corporation

CRYOAmerican CryoStem Corporation$0.00-99.75%

CRXMGene Biotherapeutics, Inc.

CRXMGene Biotherapeutics, Inc.$0.00+9900.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$708.93-0.02%

Questions About GLSHQ

What is the current price of Gelesis?

Gelesis is trading at N/A per share.

What is the 52-week range for Gelesis?

Over the past 52 weeks, Gelesis has traded between N/A and $0.00.

How much debt does Gelesis have?

As of the most recent reporting period, Gelesis reported total debt of $62.26M.

How much cash does Gelesis have on hand?

Gelesis reported $7.41M in cash and cash equivalents in its most recent financial results.

What is Gelesis’s dividend yield?

Gelesis does not currently have a dividend yield.

Gelesis

Gelesis Financials at a Glance

GLSHQ News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Gelesis

GLSHQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Gelesis Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GLSHQ

What is the current price of Gelesis?

What is the 52-week range for Gelesis?

How much debt does Gelesis have?

How much cash does Gelesis have on hand?

What is Gelesis’s dividend yield?

Premium Investing Services